Navigation Links
Video: Celebrities and Professional Athletes Invite the Public to Join them at the Third Annual National Walk for Epilepsy on March 28, in Washington, D.C.
Date:2/4/2009

TITUSVILLE, N.J., Feb. 4 /PRNewswire/ -- Several big names in professional football and television will descend upon the nation's Capitol on Saturday, March 28 for the Third Annual National Walk for Epilepsy. New York Jets offensive lineman and eight-time Pro Bowler, Alan Faneca, and Atlanta Falcons running back Jason Snelling, both diagnosed with epilepsy as teenagers, will be leading their own teams of friends, relatives and fans. Together they help demonstrate that people with this neurological condition can break through barriers and achieve their dreams. The event, hosted by the Epilepsy Foundation, with financial support from Ortho-McNeil Neurologics(R), Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc, is designed to bring awareness to epilepsy and raise funds that will create much needed programs for people with epilepsy and help in the search for a cure.

To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/walkforepilepsy/36523/

Other celebrities on hand will include Walk Chairperson Greg Grunberg, star of NBC's "Heroes," whose son has epilepsy.

"My family and I know firsthand the stigma people with epilepsy face everyday," said Faneca. "The Walk is the perfect opportunity to educate the world about epilepsy and also empower those impacted by the condition to speak out."

Faneca and his 3-year-old daughter Anabelle both suffer from seizures. Faneca experienced his first seizure on Christmas Eve in 1990. Anabelle's seizures are a result of a congenital condition, which she was diagnosed with at age one. Alan and his wife Julie have become leaders in the epilepsy community, sharing their personal story with the public, fundraising for the cause and lobbying for legislation to ensure that families get much needed respite care.

The Fanecas have registered team "Pave the Way" in the National Walk for Epilepsy and hope to recruit friends and family as well as the general public to raise funds and walk with them. To register for or sponsor the Fanecas' team, visit www.WalkForEpilepsy.org and search for team name Pave the Way.

Snelling also will lead a team in the Walk. To support his team, visit www.WalkForEpilepsy.org and search for team name Rush to Support Epilepsy.

The route is slightly more than two miles and winds throughout the scenic area surrounding the National Mall. In 2008, more than 400 teams participated in the event. Over the span of two years, the National Walk for Epilepsy has raised more than $2 million, and engaged over 13,000 people, and this year, the Epilepsy Foundation hopes to continue the momentum.

Event pre-registration is required and costs are $35 per walker for adults and $20 for children 12 and under. Those who are unable to join the walkers in Washington, D.C. are encouraged to support the event virtually in their own community. For more information, to make a donation or register for the event, visit www.WalkforEpilepsy.org.

"Although the stigma surrounding epilepsy has progressively diminished during the past century, there are still many misconceptions about this condition," said Eric R. Hargis, president and CEO of the Epilepsy Foundation. "We are grateful to the thousands of individuals and families who participate in the Walk. With their support, we are able to educate people about epilepsy and raise funds to support the Epilepsy Foundation's mission."

About Epilepsy

Epilepsy is a serious neurological condition that can develop at any time in life, but there is a particular susceptibility in young children and the elderly. The condition produces seizures, which can range from a momentary disruption of the senses, to short periods of unconsciousness or staring spells, to convulsions. A seizure happens when a brief, strong surge of electrical activity affects part or all of the brain. When a person has two or more unprovoked seizures, they are considered to have epilepsy. Currently there is no cure for epilepsy; however, more than half of people with epilepsy are able to control seizures with existing treatment options.

The Epilepsy Foundation

The Epilepsy Foundation is a nonprofit organization with the goal of ensuring that people with seizures are able to participate in all life experiences, and works to prevent, control and cure epilepsy through services, education, advocacy and research. For more information, visit www.EpilepsyFoundation.org.

Ortho-McNeil Neurologics(R)

Headquartered in Titusville, N.J., Ortho-McNeil Neurologics(R), Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc, focuses exclusively on providing solutions that improve neurological health. The company has products for Alzheimer's disease, epilepsy, and acute and preventive migraine treatment. Ortho-McNeil Neurologics(R), in conjunction with internal and external research partners, continues to explore new opportunities to develop solutions for unmet healthcare needs in neurology. For more information, visit www.OrthoMcNeilNeurologics.com.


'/>"/>
SOURCE Ortho-McNeil Neurologics
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Video: Nutrition Comes to NASCAR
2. Video: Circulatory Care of New Jersey
3. Video: GEN Video Hits Home with Web Audience
4. Video: Beyond the Red Door: Gildas Club Worldwide and DKNY Host Successful Benefit Event
5. Video: Food Expert B. Smith to Provide Healthy Menu Makeovers
6. Video: New FDA-Approved Sun Protectant Saves Skin All Year Round
7. Video: Kyphon Supports World Osteoporosis Day on October 20, 2007 to Raise Awareness of Osteoporosis and Spinal Fracture Risk
8. Video: Trinity Mother Frances Neurosurgeon First in Region to Remove Brain Tumor Using Unique Surgical Procedure
9. Video: Holiday Safety Is Important
10. Video: Grin Big With an Award-Winning Smile
11. Video: BSP Pharma Inc. Announces Groundbreaking Findings from The Australian Centre for Complementary Medicine Education and Research Joint Health Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... WI (PRWEB) , ... October 13, 2017 , ... As ... in medicine known as “patient engagement.” The patient is doing more than filling out ... partners. , “There is an increasing emphasis in health care and research on ...
(Date:10/13/2017)... ... ... The American Board of Family Medicine's (ABFM) Board of Directors has selected ... Dr. James C. Puffer upon his retirement. Dr. Newton will serve in the position ... the end of 2018. Upon assuming the role of President and CEO on January ...
(Date:10/13/2017)... ... , ... PurhealthRX , a leading Health and Nutrition Company, is announcing ... full spectrum CBD oil will revolutionize the rapidly growing CBD market by reducing the ... incorporated into liquid products, while reducing costs to end users. , The team of ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder of ... ElderCounsel, a national organization of elder law and special needs planning attorneys. “Membership in ... It also provides a forum to network with elder law attorneys nationwide,” said Somekh. ...
(Date:10/13/2017)... LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for care ... is the 90-day elimination period, when the family pays for care, is often waived, ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, Inc. ... response letter from the U.S. Food and Drug Administration ... of sirukumab for the treatment of moderately to severely ... additional clinical data are needed to further evaluate the ... severely active RA. ...
(Date:9/19/2017)... Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses ... today:   ... Jim ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and business ...
(Date:9/18/2017)... PROVIDENCE, R.I. , Sept. 18, 2017 ... in the fields of bioinformatics and immune ... to develop a protective avian influenza A (H7N9) vaccine. ... is distantly related to seasonal influenza and ... approaches, which rely on prior exposure to be ...
Breaking Medicine Technology: